Aldoxorubicin
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Aldoxorubicin, covering 2015-10-22 to 2024-06-25. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer [Phase 2]